Oncogene deal

ONCS (Uniondale, N.Y.) and Aston Molecules Ltd. (U.K.) will optimize ONCS's lead compounds for chronic myelogenous leukemia and HIV using Aston's medicinal chemistry capabilities. ONCS will fund medic...